Swenerton K - Search Results

1

Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).

Oza AM, Elit L, Swenerton K, Faught W, Ghatage P, Carey M, McIntosh L, Dorr A, Holmlund JT, Eisenhauer E; NCIC Clinical Trials Group Study (NCIC IND.116). Oza AM, et al. Among authors: swenerton k. Gynecol Oncol. 2003 Apr;89(1):129-33. doi: 10.1016/s0090-8258(02)00144-0. Gynecol Oncol. 2003. PMID: 12694666 Clinical Trial.

2

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.

Mackay HJ, Tinker A, Winquist E, Thomas G, Swenerton K, Oza A, Sederias J, Ivy P, Eisenhauer EA. Mackay HJ, et al. Among authors: swenerton k. Gynecol Oncol. 2010 Feb;116(2):163-7. doi: 10.1016/j.ygyno.2009.08.012. Epub 2009 Sep 8. Gynecol Oncol. 2010. PMID: 19740535 Clinical Trial.

3

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149).

Hirte H, Oza A, Swenerton K, Ellard SL, Grimshaw R, Fisher B, Tsao M, Seymour L. Hirte H, et al. Among authors: swenerton k. Gynecol Oncol. 2010 Sep;118(3):308-12. doi: 10.1016/j.ygyno.2010.05.005. Epub 2010 Jun 19. Gynecol Oncol. 2010. PMID: 20646751 Clinical Trial.

4

Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies.

Lê LH, Swenerton KD, Elit L, Provencher DM, Stuart GC, LE T, Lee U, Rodgers A, Pond GR, Hu H, Oza AM. Lê LH, et al. Among authors: swenerton kd. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):799-806. doi: 10.1111/j.1525-1438.2005.00139.x. Int J Gynecol Cancer. 2005. PMID: 16174227 Free article. Clinical Trial.

5

A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.

Swenerton K, Hoskins P, Stuart G, Batist G, Pike J, Onetto N, Fisher B, Eisenhauer E. Swenerton K, et al. Ann Oncol. 1996 Dec;7(10):1077-9. doi: 10.1093/oxfordjournals.annonc.a010502. Ann Oncol. 1996. PMID: 9037368 Free article. Clinical Trial.

6

Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

Dark GG, Calvert AH, Grimshaw R, Poole C, Swenerton K, Kaye S, Coleman R, Jayson G, Le T, Ellard S, Trudeau M, Vasey P, Hamilton M, Cameron T, Barrett E, Walsh W, McIntosh L, Eisenhauer EA. Dark GG, et al. Among authors: swenerton k. J Clin Oncol. 2005 Mar 20;23(9):1859-66. doi: 10.1200/JCO.2005.02.028. Epub 2005 Feb 7. J Clin Oncol. 2005. PMID: 15699482 Clinical Trial.

7

Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinoma.

Rusthoven JJ, Eisenhauer E, Mazurka J, Hirte H, O'Connell G, Muldal A, Lu HX, Onetto N, Swenerton K, Jeffrey J. Rusthoven JJ, et al. Among authors: swenerton k. J Natl Cancer Inst. 1993 May 19;85(10):823-5. doi: 10.1093/jnci/85.10.823. J Natl Cancer Inst. 1993. PMID: 8487328 Clinical Trial. No abstract available.

8

Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Canadian-European Taxol Cooperative Trial Group.

ten Bokkel Huinink WW, Eisenhauer E, Swenerton K. ten Bokkel Huinink WW, et al. Among authors: swenerton k. Cancer Treat Rev. 1993;19 Suppl C:79-86. doi: 10.1016/0305-7372(93)90050-2. Cancer Treat Rev. 1993. PMID: 8106156 Clinical Trial.

9

Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.

Eisenhauer EA, Swenerton KD, Sturgeon JF, Fine S, O'Reilly SE. Eisenhauer EA, et al. Among authors: swenerton kd. Cancer Treat Rep. 1986 Oct;70(10):1195-8. Cancer Treat Rep. 1986. PMID: 3530446

10

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

Eisenhauer EA, ten Bokkel Huinink WW, Swenerton KD, Gianni L, Myles J, van der Burg ME, Kerr I, Vermorken JB, Buser K, Colombo N, et al. Eisenhauer EA, et al. Among authors: swenerton kd. J Clin Oncol. 1994 Dec;12(12):2654-66. doi: 10.1200/JCO.1994.12.12.2654. J Clin Oncol. 1994. PMID: 7989941 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page